Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0030870 | Mre11 complex | 3 | 3 |
GO:0032991 | protein-containing complex | 1 | 3 |
GO:0035861 | site of double-strand break | 3 | 2 |
GO:0090734 | site of DNA damage | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
GO:0140513 | nuclear protein-containing complex | 2 | 3 |
GO:0005634 | nucleus | 5 | 4 |
GO:0043226 | organelle | 2 | 4 |
GO:0043227 | membrane-bounded organelle | 3 | 4 |
GO:0043229 | intracellular organelle | 3 | 4 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 4 |
Related structures:
AlphaFold database: E9ADG7
Term | Name | Level | Count |
---|---|---|---|
GO:0000075 | cell cycle checkpoint signaling | 4 | 2 |
GO:0000077 | DNA damage checkpoint signaling | 5 | 2 |
GO:0000723 | telomere maintenance | 5 | 2 |
GO:0000724 | double-strand break repair via homologous recombination | 7 | 2 |
GO:0000725 | recombinational repair | 6 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 7 |
GO:0006259 | DNA metabolic process | 4 | 7 |
GO:0006281 | DNA repair | 5 | 7 |
GO:0006302 | double-strand break repair | 6 | 7 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 7 | 2 |
GO:0006310 | DNA recombination | 5 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0006950 | response to stress | 2 | 7 |
GO:0006974 | DNA damage response | 4 | 7 |
GO:0006996 | organelle organization | 4 | 2 |
GO:0007093 | mitotic cell cycle checkpoint signaling | 4 | 2 |
GO:0007095 | mitotic G2 DNA damage checkpoint signaling | 6 | 2 |
GO:0007165 | signal transduction | 2 | 2 |
GO:0007346 | regulation of mitotic cell cycle | 5 | 2 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0009987 | cellular process | 1 | 7 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 7 | 2 |
GO:0010564 | regulation of cell cycle process | 5 | 2 |
GO:0010948 | negative regulation of cell cycle process | 6 | 2 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 8 | 2 |
GO:0016043 | cellular component organization | 3 | 2 |
GO:0022402 | cell cycle process | 2 | 2 |
GO:0022414 | reproductive process | 1 | 3 |
GO:0031570 | DNA integrity checkpoint signaling | 5 | 2 |
GO:0032200 | telomere organization | 6 | 2 |
GO:0033554 | cellular response to stress | 3 | 7 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 7 |
GO:0035556 | intracellular signal transduction | 3 | 2 |
GO:0042138 | meiotic DNA double-strand break formation | 4 | 2 |
GO:0042770 | signal transduction in response to DNA damage | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 7 |
GO:0044237 | cellular metabolic process | 2 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 7 |
GO:0044773 | mitotic DNA damage checkpoint signaling | 6 | 2 |
GO:0044774 | mitotic DNA integrity checkpoint signaling | 5 | 2 |
GO:0044818 | mitotic G2/M transition checkpoint | 5 | 2 |
GO:0045786 | negative regulation of cell cycle | 5 | 2 |
GO:0045930 | negative regulation of mitotic cell cycle | 6 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 7 |
GO:0048519 | negative regulation of biological process | 3 | 2 |
GO:0048523 | negative regulation of cellular process | 4 | 2 |
GO:0050789 | regulation of biological process | 2 | 2 |
GO:0050794 | regulation of cellular process | 3 | 2 |
GO:0050896 | response to stimulus | 1 | 7 |
GO:0051276 | chromosome organization | 5 | 2 |
GO:0051716 | cellular response to stimulus | 2 | 7 |
GO:0051726 | regulation of cell cycle | 4 | 2 |
GO:0061982 | meiosis I cell cycle process | 3 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:0071840 | cellular component organization or biogenesis | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 7 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5 | 2 |
GO:0097551 | mitochondrial double-strand break repair | 7 | 2 |
GO:0097552 | mitochondrial double-strand break repair via homologous recombination | 7 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 7 |
GO:1901987 | regulation of cell cycle phase transition | 6 | 2 |
GO:1901988 | negative regulation of cell cycle phase transition | 7 | 2 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 6 | 2 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 7 | 2 |
GO:1902749 | regulation of cell cycle G2/M phase transition | 7 | 2 |
GO:1902750 | negative regulation of cell cycle G2/M phase transition | 8 | 2 |
GO:1903046 | meiotic cell cycle process | 2 | 2 |
GO:1903047 | mitotic cell cycle process | 3 | 2 |
GO:0007049 | cell cycle | 2 | 1 |
GO:0051321 | meiotic cell cycle | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000014 | single-stranded DNA endodeoxyribonuclease activity | 6 | 2 |
GO:0003824 | catalytic activity | 1 | 7 |
GO:0004518 | nuclease activity | 4 | 7 |
GO:0004519 | endonuclease activity | 5 | 7 |
GO:0004520 | DNA endonuclease activity | 5 | 3 |
GO:0004527 | exonuclease activity | 5 | 7 |
GO:0004536 | DNA nuclease activity | 4 | 3 |
GO:0005488 | binding | 1 | 7 |
GO:0016787 | hydrolase activity | 2 | 7 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 7 |
GO:0030145 | manganese ion binding | 6 | 7 |
GO:0043167 | ion binding | 2 | 7 |
GO:0043169 | cation binding | 3 | 7 |
GO:0046872 | metal ion binding | 4 | 7 |
GO:0046914 | transition metal ion binding | 5 | 7 |
GO:0140097 | catalytic activity, acting on DNA | 3 | 3 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 3 |
GO:0004529 | DNA exonuclease activity | 5 | 1 |
GO:0008296 | 3'-5'-DNA exonuclease activity | 7 | 1 |
GO:0008408 | 3'-5' exonuclease activity | 6 | 1 |
GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 1 |
GO:0016895 | DNA exonuclease activity, producing 5'-phosphomonoesters | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 311 | 315 | PF00656 | 0.475 |
CLV_C14_Caspase3-7 | 800 | 804 | PF00656 | 0.581 |
CLV_NRD_NRD_1 | 161 | 163 | PF00675 | 0.312 |
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.352 |
CLV_NRD_NRD_1 | 303 | 305 | PF00675 | 0.275 |
CLV_NRD_NRD_1 | 405 | 407 | PF00675 | 0.295 |
CLV_NRD_NRD_1 | 496 | 498 | PF00675 | 0.469 |
CLV_NRD_NRD_1 | 573 | 575 | PF00675 | 0.604 |
CLV_NRD_NRD_1 | 641 | 643 | PF00675 | 0.637 |
CLV_NRD_NRD_1 | 73 | 75 | PF00675 | 0.312 |
CLV_NRD_NRD_1 | 743 | 745 | PF00675 | 0.603 |
CLV_NRD_NRD_1 | 771 | 773 | PF00675 | 0.843 |
CLV_PCSK_FUR_1 | 639 | 643 | PF00082 | 0.636 |
CLV_PCSK_KEX2_1 | 24 | 26 | PF00082 | 0.352 |
CLV_PCSK_KEX2_1 | 303 | 305 | PF00082 | 0.275 |
CLV_PCSK_KEX2_1 | 405 | 407 | PF00082 | 0.295 |
CLV_PCSK_KEX2_1 | 496 | 498 | PF00082 | 0.469 |
CLV_PCSK_KEX2_1 | 520 | 522 | PF00082 | 0.477 |
CLV_PCSK_KEX2_1 | 572 | 574 | PF00082 | 0.616 |
CLV_PCSK_KEX2_1 | 641 | 643 | PF00082 | 0.637 |
CLV_PCSK_KEX2_1 | 690 | 692 | PF00082 | 0.618 |
CLV_PCSK_KEX2_1 | 743 | 745 | PF00082 | 0.563 |
CLV_PCSK_KEX2_1 | 771 | 773 | PF00082 | 0.843 |
CLV_PCSK_PC1ET2_1 | 520 | 522 | PF00082 | 0.477 |
CLV_PCSK_PC1ET2_1 | 690 | 692 | PF00082 | 0.618 |
CLV_PCSK_PC7_1 | 299 | 305 | PF00082 | 0.275 |
CLV_PCSK_SKI1_1 | 397 | 401 | PF00082 | 0.275 |
CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.312 |
CLV_PCSK_SKI1_1 | 75 | 79 | PF00082 | 0.342 |
CLV_PCSK_SKI1_1 | 825 | 829 | PF00082 | 0.658 |
CLV_Separin_Metazoa | 35 | 39 | PF03568 | 0.312 |
CLV_Separin_Metazoa | 394 | 398 | PF03568 | 0.475 |
CLV_Separin_Metazoa | 580 | 584 | PF03568 | 0.606 |
DEG_APCC_KENBOX_2 | 544 | 548 | PF00400 | 0.516 |
DOC_CYCLIN_RxL_1 | 4 | 13 | PF00134 | 0.312 |
DOC_CYCLIN_yCln2_LP_2 | 395 | 401 | PF00134 | 0.529 |
DOC_CYCLIN_yCln2_LP_2 | 426 | 432 | PF00134 | 0.512 |
DOC_MAPK_FxFP_2 | 192 | 195 | PF00069 | 0.291 |
DOC_MAPK_gen_1 | 162 | 170 | PF00069 | 0.312 |
DOC_MAPK_gen_1 | 183 | 192 | PF00069 | 0.339 |
DOC_MAPK_gen_1 | 639 | 648 | PF00069 | 0.545 |
DOC_MAPK_MEF2A_6 | 355 | 363 | PF00069 | 0.475 |
DOC_PP1_RVXF_1 | 186 | 193 | PF00149 | 0.291 |
DOC_PP1_SILK_1 | 504 | 509 | PF00149 | 0.597 |
DOC_PP2B_LxvP_1 | 246 | 249 | PF13499 | 0.397 |
DOC_PP2B_LxvP_1 | 426 | 429 | PF13499 | 0.527 |
DOC_PP4_FxxP_1 | 105 | 108 | PF00568 | 0.312 |
DOC_PP4_FxxP_1 | 192 | 195 | PF00568 | 0.291 |
DOC_USP7_MATH_1 | 502 | 506 | PF00917 | 0.518 |
DOC_USP7_MATH_1 | 563 | 567 | PF00917 | 0.759 |
DOC_USP7_MATH_1 | 673 | 677 | PF00917 | 0.713 |
DOC_USP7_MATH_1 | 829 | 833 | PF00917 | 0.607 |
DOC_WW_Pin1_4 | 288 | 293 | PF00397 | 0.503 |
DOC_WW_Pin1_4 | 561 | 566 | PF00397 | 0.732 |
DOC_WW_Pin1_4 | 608 | 613 | PF00397 | 0.634 |
LIG_14-3-3_CanoR_1 | 162 | 168 | PF00244 | 0.312 |
LIG_14-3-3_CanoR_1 | 284 | 289 | PF00244 | 0.409 |
LIG_14-3-3_CanoR_1 | 303 | 307 | PF00244 | 0.475 |
LIG_14-3-3_CanoR_1 | 38 | 46 | PF00244 | 0.312 |
LIG_14-3-3_CanoR_1 | 68 | 73 | PF00244 | 0.312 |
LIG_14-3-3_CanoR_1 | 691 | 700 | PF00244 | 0.664 |
LIG_Actin_WH2_2 | 147 | 164 | PF00022 | 0.388 |
LIG_Actin_WH2_2 | 382 | 399 | PF00022 | 0.475 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.577 |
LIG_BIR_III_2 | 803 | 807 | PF00653 | 0.580 |
LIG_BRCT_BRCA1_1 | 643 | 647 | PF00533 | 0.546 |
LIG_BRCT_BRCA1_2 | 643 | 649 | PF00533 | 0.550 |
LIG_EH1_1 | 43 | 51 | PF00400 | 0.312 |
LIG_FHA_1 | 128 | 134 | PF00498 | 0.312 |
LIG_FHA_1 | 3 | 9 | PF00498 | 0.291 |
LIG_FHA_1 | 303 | 309 | PF00498 | 0.542 |
LIG_FHA_1 | 434 | 440 | PF00498 | 0.486 |
LIG_FHA_1 | 67 | 73 | PF00498 | 0.326 |
LIG_FHA_1 | 722 | 728 | PF00498 | 0.828 |
LIG_FHA_1 | 95 | 101 | PF00498 | 0.402 |
LIG_FHA_2 | 147 | 153 | PF00498 | 0.312 |
LIG_FHA_2 | 29 | 35 | PF00498 | 0.312 |
LIG_FHA_2 | 40 | 46 | PF00498 | 0.312 |
LIG_FHA_2 | 798 | 804 | PF00498 | 0.583 |
LIG_Integrin_RGD_1 | 25 | 27 | PF01839 | 0.312 |
LIG_LIR_Apic_2 | 370 | 376 | PF02991 | 0.475 |
LIG_LIR_Gen_1 | 165 | 173 | PF02991 | 0.316 |
LIG_LIR_Gen_1 | 253 | 260 | PF02991 | 0.401 |
LIG_LIR_Gen_1 | 27 | 37 | PF02991 | 0.312 |
LIG_LIR_Gen_1 | 364 | 373 | PF02991 | 0.475 |
LIG_LIR_Gen_1 | 577 | 587 | PF02991 | 0.604 |
LIG_LIR_Nem_3 | 138 | 144 | PF02991 | 0.338 |
LIG_LIR_Nem_3 | 165 | 170 | PF02991 | 0.316 |
LIG_LIR_Nem_3 | 253 | 258 | PF02991 | 0.412 |
LIG_LIR_Nem_3 | 27 | 33 | PF02991 | 0.312 |
LIG_LIR_Nem_3 | 3 | 9 | PF02991 | 0.348 |
LIG_LIR_Nem_3 | 364 | 368 | PF02991 | 0.475 |
LIG_LIR_Nem_3 | 493 | 498 | PF02991 | 0.456 |
LIG_LIR_Nem_3 | 71 | 76 | PF02991 | 0.350 |
LIG_LYPXL_yS_3 | 356 | 359 | PF13949 | 0.475 |
LIG_NRBOX | 482 | 488 | PF00104 | 0.454 |
LIG_PALB2_WD40_1 | 199 | 207 | PF16756 | 0.312 |
LIG_PCNA_yPIPBox_3 | 216 | 229 | PF02747 | 0.291 |
LIG_Pex14_1 | 849 | 853 | PF04695 | 0.511 |
LIG_Pex14_2 | 604 | 608 | PF04695 | 0.717 |
LIG_SH2_GRB2like | 141 | 144 | PF00017 | 0.312 |
LIG_SH2_NCK_1 | 527 | 531 | PF00017 | 0.557 |
LIG_SH2_STAP1 | 527 | 531 | PF00017 | 0.505 |
LIG_SH2_STAT5 | 141 | 144 | PF00017 | 0.312 |
LIG_SH2_STAT5 | 293 | 296 | PF00017 | 0.475 |
LIG_SH2_STAT5 | 76 | 79 | PF00017 | 0.312 |
LIG_SH3_3 | 109 | 115 | PF00018 | 0.505 |
LIG_SH3_3 | 245 | 251 | PF00018 | 0.405 |
LIG_SH3_3 | 254 | 260 | PF00018 | 0.386 |
LIG_SH3_3 | 386 | 392 | PF00018 | 0.475 |
LIG_SH3_3 | 395 | 401 | PF00018 | 0.475 |
LIG_SH3_3 | 426 | 432 | PF00018 | 0.466 |
LIG_SH3_3 | 581 | 587 | PF00018 | 0.748 |
LIG_SH3_3 | 630 | 636 | PF00018 | 0.634 |
LIG_SH3_3 | 682 | 688 | PF00018 | 0.780 |
LIG_SH3_3 | 816 | 822 | PF00018 | 0.698 |
LIG_SUMO_SIM_anti_2 | 130 | 138 | PF11976 | 0.312 |
LIG_TRAF2_1 | 269 | 272 | PF00917 | 0.425 |
LIG_TRAF2_1 | 32 | 35 | PF00917 | 0.312 |
LIG_TRFH_1 | 288 | 292 | PF08558 | 0.475 |
LIG_TYR_ITIM | 354 | 359 | PF00017 | 0.475 |
LIG_UBA3_1 | 483 | 492 | PF00899 | 0.451 |
LIG_WRC_WIRS_1 | 30 | 35 | PF05994 | 0.312 |
LIG_WRC_WIRS_1 | 321 | 326 | PF05994 | 0.475 |
MOD_CDK_SPxxK_3 | 608 | 615 | PF00069 | 0.532 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.474 |
MOD_CK1_1 | 29 | 35 | PF00069 | 0.312 |
MOD_CK1_1 | 327 | 333 | PF00069 | 0.478 |
MOD_CK1_1 | 490 | 496 | PF00069 | 0.471 |
MOD_CK1_1 | 847 | 853 | PF00069 | 0.579 |
MOD_CK1_1 | 86 | 92 | PF00069 | 0.312 |
MOD_CK2_1 | 146 | 152 | PF00069 | 0.291 |
MOD_CK2_1 | 266 | 272 | PF00069 | 0.419 |
MOD_CK2_1 | 28 | 34 | PF00069 | 0.312 |
MOD_CK2_1 | 331 | 337 | PF00069 | 0.529 |
MOD_CK2_1 | 456 | 462 | PF00069 | 0.493 |
MOD_CK2_1 | 595 | 601 | PF00069 | 0.679 |
MOD_GlcNHglycan | 268 | 271 | PF01048 | 0.506 |
MOD_GlcNHglycan | 369 | 372 | PF01048 | 0.275 |
MOD_GlcNHglycan | 423 | 426 | PF01048 | 0.288 |
MOD_GlcNHglycan | 462 | 466 | PF01048 | 0.295 |
MOD_GlcNHglycan | 595 | 598 | PF01048 | 0.740 |
MOD_GlcNHglycan | 643 | 646 | PF01048 | 0.653 |
MOD_GlcNHglycan | 693 | 696 | PF01048 | 0.647 |
MOD_GlcNHglycan | 768 | 771 | PF01048 | 0.669 |
MOD_GlcNHglycan | 777 | 780 | PF01048 | 0.594 |
MOD_GlcNHglycan | 786 | 789 | PF01048 | 0.518 |
MOD_GlcNHglycan | 797 | 800 | PF01048 | 0.606 |
MOD_GlcNHglycan | 816 | 819 | PF01048 | 0.541 |
MOD_GlcNHglycan | 831 | 834 | PF01048 | 0.776 |
MOD_GSK3_1 | 259 | 266 | PF00069 | 0.405 |
MOD_GSK3_1 | 284 | 291 | PF00069 | 0.399 |
MOD_GSK3_1 | 320 | 327 | PF00069 | 0.511 |
MOD_GSK3_1 | 363 | 370 | PF00069 | 0.475 |
MOD_GSK3_1 | 449 | 456 | PF00069 | 0.447 |
MOD_GSK3_1 | 486 | 493 | PF00069 | 0.452 |
MOD_GSK3_1 | 589 | 596 | PF00069 | 0.664 |
MOD_GSK3_1 | 825 | 832 | PF00069 | 0.656 |
MOD_GSK3_1 | 86 | 93 | PF00069 | 0.371 |
MOD_N-GLC_1 | 449 | 454 | PF02516 | 0.247 |
MOD_N-GLC_1 | 502 | 507 | PF02516 | 0.600 |
MOD_N-GLC_2 | 453 | 455 | PF02516 | 0.416 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.414 |
MOD_NEK2_1 | 135 | 140 | PF00069 | 0.352 |
MOD_NEK2_1 | 324 | 329 | PF00069 | 0.478 |
MOD_NEK2_1 | 486 | 491 | PF00069 | 0.439 |
MOD_NEK2_1 | 591 | 596 | PF00069 | 0.689 |
MOD_NEK2_1 | 66 | 71 | PF00069 | 0.243 |
MOD_OFUCOSY | 65 | 70 | PF10250 | 0.243 |
MOD_PIKK_1 | 487 | 493 | PF00454 | 0.445 |
MOD_PKA_1 | 162 | 168 | PF00069 | 0.388 |
MOD_PKA_1 | 641 | 647 | PF00069 | 0.545 |
MOD_PKA_2 | 283 | 289 | PF00069 | 0.418 |
MOD_PKA_2 | 302 | 308 | PF00069 | 0.592 |
MOD_PKA_2 | 641 | 647 | PF00069 | 0.604 |
MOD_PKA_2 | 765 | 771 | PF00069 | 0.636 |
MOD_PKB_1 | 639 | 647 | PF00069 | 0.543 |
MOD_Plk_1 | 2 | 8 | PF00069 | 0.398 |
MOD_Plk_1 | 26 | 32 | PF00069 | 0.321 |
MOD_Plk_1 | 502 | 508 | PF00069 | 0.599 |
MOD_Plk_1 | 720 | 726 | PF00069 | 0.654 |
MOD_Plk_2-3 | 314 | 320 | PF00069 | 0.475 |
MOD_Plk_2-3 | 331 | 337 | PF00069 | 0.475 |
MOD_Plk_2-3 | 658 | 664 | PF00069 | 0.677 |
MOD_Plk_4 | 163 | 169 | PF00069 | 0.317 |
MOD_Plk_4 | 260 | 266 | PF00069 | 0.371 |
MOD_Plk_4 | 320 | 326 | PF00069 | 0.475 |
MOD_Plk_4 | 453 | 459 | PF00069 | 0.475 |
MOD_Plk_4 | 490 | 496 | PF00069 | 0.456 |
MOD_Plk_4 | 502 | 508 | PF00069 | 0.562 |
MOD_Plk_4 | 673 | 679 | PF00069 | 0.606 |
MOD_Plk_4 | 68 | 74 | PF00069 | 0.312 |
MOD_Plk_4 | 806 | 812 | PF00069 | 0.641 |
MOD_ProDKin_1 | 288 | 294 | PF00069 | 0.503 |
MOD_ProDKin_1 | 561 | 567 | PF00069 | 0.732 |
MOD_ProDKin_1 | 608 | 614 | PF00069 | 0.629 |
MOD_SUMO_for_1 | 401 | 404 | PF00179 | 0.529 |
MOD_SUMO_rev_2 | 54 | 62 | PF00179 | 0.312 |
TRG_DiLeu_BaEn_1 | 242 | 247 | PF01217 | 0.373 |
TRG_DiLeu_BaLyEn_6 | 354 | 359 | PF01217 | 0.529 |
TRG_ENDOCYTIC_2 | 278 | 281 | PF00928 | 0.355 |
TRG_ENDOCYTIC_2 | 356 | 359 | PF00928 | 0.475 |
TRG_ENDOCYTIC_2 | 385 | 388 | PF00928 | 0.475 |
TRG_ER_diArg_1 | 23 | 25 | PF00400 | 0.312 |
TRG_ER_diArg_1 | 302 | 304 | PF00400 | 0.475 |
TRG_ER_diArg_1 | 405 | 407 | PF00400 | 0.549 |
TRG_ER_diArg_1 | 495 | 497 | PF00400 | 0.494 |
TRG_ER_diArg_1 | 572 | 574 | PF00400 | 0.627 |
TRG_ER_diArg_1 | 639 | 642 | PF00400 | 0.717 |
TRG_ER_diArg_1 | 743 | 746 | PF00400 | 0.565 |
TRG_NES_CRM1_1 | 226 | 242 | PF08389 | 0.312 |
TRG_NES_CRM1_1 | 433 | 445 | PF08389 | 0.475 |
TRG_NLS_MonoExtN_4 | 687 | 694 | PF00514 | 0.692 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PB75 | Leptomonas seymouri | 63% | 98% |
A0A3Q8IDJ4 | Leishmania donovani | 94% | 99% |
A4HFW3 | Leishmania braziliensis | 83% | 99% |
A4I2Z5 | Leishmania infantum | 94% | 99% |
E9AZ91 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 99% |